Bioanalytical
assays are often affected by the presence of either exogenous or endogenous
interfering matrix components, in samples assayed for the targeted analytes
such as the disease associated biomarkers, in molecular diagnosis. Whole blood,as one of the most preferred samples, is known for its complex matrix andsometimes characterized to be ‘dirty’ due to presence of the interfering
hemoglobin found in higher levels than the targeted analytes that often exist
at trace levels. In this case, hemoglobin as the interferent poses a challenge
when whole blood is directly introduced in to sensitive analytical instruments
such as gas chromatography mass spectrometry (GC-MS) or liquid chromatography
tandem mass spectrometry (LCMS/ MS) as sensitive and specific detection systems
of choice.
On the other hand, hemoglobin usually masks the targeted analytes
from being easily detected, thus, clog the instrument’s components more
especially the columns, which end up being plugged and inactivated during chromatographic
separation, leading to interference, imprecise and inaccurate results after a
few runs. Furthermore, when not removed, hemoglobin generally leads to matrix
effects caused by its co-elution with the biomarkers, which are the targeted
analytes. Consequently, prior to employing sensitive instruments with low
detection and quantification limits, whole blood as a sample must undergo
extensive sample preparation to eliminate the matrix interferents as well as to
achieve even more accurate and precise results.(Read More)
No comments:
Post a Comment